Compositions and methods for treating CNS disorders
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- SAGE THERAPEUTICS
- Publication Date
- 2019-06-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. Ser. No. 15 / 519,480 filed Apr. 14, 2017, which is a U.S. National Stage Application filed under 35 U.S.C. § 371 of International Patent Application No. PCT / US2015 / 056054, filed Oct. 16, 2015, which claims priority to U.S. Provisional Application No. 62 / 064,961, filed Oct. 16, 2014, the entire contents of which are incorporated herein by reference.BACKGROUND OF THE INVENTION
[0002] Brain excitability is defined as the level of arousal of an animal, a continuum that ranges from coma to convulsions, and is regulated by various neurotransmitters. In general, neurotransmitters are responsible for regulating the conductance of ions across neuronal membranes. At rest, the neuronal membrane possesses a potential (or membrane voltage) of approximately −70 mV, the cell interior being negative with respect to the cell exterior. The potential (voltage) is the result of ion (K+, Na+, Cl−, organic anions) balance across the neuron...